Skip to main content

Table 3 Intergroup comparison of SF-36 somatic and mental scores at baseline and at 3, 6 and 12 months of women on 24/4 regimen 17β-estradiol (1.5 mg) and Nomegestrol Acetate (2.5 mg) (E2/NOMAC) combined oral contraceptive, or on Dienogest (DNG) 2 mg daily

From: Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain

SF-36 somatic score

Baseline

3rd month follow-up

6th month follow-up

12th month follow-up

A

    

E2/NOMAC Group

60 ± 10

68 ± 10

75 ± 8

80 ± 11

DNG Group

57 ± 18

70 ± 7

80 ± 19

84 ± 9

p

0.18

95% CI − 1.08 to 7.08

0.1

95% CI − 4.42 to − 0.42

0.01

95% CI − 9.08 to − 0.91

0.006

95% CI − 6.82 to − 1.17

SF-36 mental score

Baseline

3rd month follow-up

6th month follow-up

12th month follow-up

B

    

E2/NOMAC Group

60 ± 7

76 ± 8

84 ± 8

88 ± 9

DNG Group

62 ± 12

75 ± 9

86 ± 9

90 ± 10

p

0.16

95% CI − 4.75 to 0.75

0.4

95% CI − 1.39 to 3.39

0.1

95% CI − 0.41 to 0.62

0.1

95% CI − 4.67 to − 0.67

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us